Literature DB >> 10498145

Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. RAPPORT investigators. ReoPro And Primary PTCA Organization and Randomized Trial.

S J Brener1, L A Barr, J E Burchenal, K E Wolski, M B Effron, E J Topol.   

Abstract

We investigated the effect of platelet fibrinogen receptor blockade on infarct size after primary angioplasty. Abciximab significantly reduced the time-to-peak creatine kinase without affecting enzymatic infarct size, suggesting a beneficial effect on the pattern and speed of reperfusion.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10498145     DOI： 10.1016/s0002-9149(99)00421-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Acute myocardial infarction: thrombolysis.

Authors:  E J Topol
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

2.  Potential of microvascular reperfusion with adjunctive pharmacological intervention: its impact on myocardial perfusion and functional outcomes in patients with acute myocardial infarction.

Authors:  Y Taniyama; H Ito; R Morishita; T Ogihara
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Association of glycoprotein IIb/IIIa inhibitors and long-term survival following administration during percutaneous coronary intervention for acute myocardial infarction.

Authors:  Jeffrey S Berger; David L Brown
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

Review 4.  Antiplatelet agents for chronic kidney disease.

Authors:  Patrizia Natale; Suetonia C Palmer; Valeria M Saglimbene; Marinella Ruospo; Mona Razavian; Jonathan C Craig; Meg J Jardine; Angela C Webster; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2022-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.